Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
A clinical study on fall risk assessment and preventive nursing in older adults with non-Hodgkin's lymphoma undergoing chemotherapy-a randomized controlled trial.
Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-Hodgkin's lymphoma (NHL) is a diverse group of lymphoproliferative malignancies that predominantly affects older adults. Chemotherapy remains the primary modality of treatment for many NHL subtypes, yet it often brings about adverse effects such as myelosuppression, anemia, and neuropathy, all of which contribute to a heightened risk of falls in older patients. Falls in this population can lead to serious complications, including fractures and intracranial injuries, thereby impacting functional status and potentially delaying oncological treatment.
objectiveThis study was aimed at assessing the efficacy of a structured, evidence-based preventive nursing protocol in reducing falls among older patients with NHL undergoing chemotherapy compared to standard care.
methodsA prospective, single-center randomized controlled trial enrolled 210 older patients (≥ 65 years) newly diagnosed with or relapsed NHL requiring chemotherapy. Participants were randomly assigned to an Intervention Group-receiving a multifaceted preventive nursing program based on individualized risk assessment-or a Control Group that received standard oncology nursing. Primary outcomes included fall incidence and recurrence. Secondary outcomes encompassed fall-related injuries, Timed Up and Go (TUG) test performance, chemotherapy completion, and quality of life. Statistical analyses were conducted using SPSS 27.0 with significance set at p < 0.05.
resultsOf 210 participants enrolled, 194 (98 in the Intervention Group and 96 in the Control Group) completed the 12-week follow-up. The Intervention Group demonstrated a significantly lower fall incidence (7.1%) compared with the Control Group (19.8%, p = 0.012). Patients in the Intervention Group had fewer severe injuries, better chemotherapy adherence, improved functional mobility as measured by TUG tests, and higher quality of life scores.
conclusionA targeted, multifactorial nursing intervention substantially reduced falls and fall-related complications among older adults with NHL receiving chemotherapy. Integration of fall prevention measures into routine oncologic care is strongly recommended to safeguard treatment continuity and patient well-being. Further multicenter and long-term studies are warranted to validate these findings and refine comprehensive fall prevention strategies.
Indexed as
Identifiers
42470465What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.